Literature DB >> 24513265

Humanized NOD-SCID IL2rg–/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies.

Qianjun Zhou1, John Facciponte2, Min Jin3, Qiang Shen4, Qiang Lin5.   

Abstract

Humanized mouse models have been developed and utilized in cancer research for decades. Newly developed combined immunodeficient NOD-SCID-IL2rg–/– mice are more permissive for human cells and tissue engraftment. In this review, we discuss the use of NOD-SCID-IL2rg(–/–) mice as a preclinical tool in cancer research and its potential use for individualized cancer therapies.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24513265     DOI： 10.1016/j.canlet.2013.10.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  38 in total

Review 1.  Humanized Mice in Dermatology Research.

Authors:  Russell L Griffin; Thomas S Kupper; Sherrie J Divito
Journal:  J Invest Dermatol       Date:  2015-12       Impact factor: 8.551

2.  Functional expression of sodium-glucose transporters in cancer.

Authors:  Claudio Scafoglio; Bruce A Hirayama; Vladimir Kepe; Jie Liu; Chiara Ghezzi; Nagichettiar Satyamurthy; Neda A Moatamed; Jiaoti Huang; Hermann Koepsell; Jorge R Barrio; Ernest M Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

Review 3.  Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases.

Authors:  Iurii Koboziev; Yava Jones-Hall; John F Valentine; Cynthia Reinoso Webb; Kathryn L Furr; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

Review 4.  Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap.

Authors:  J Jason Morton; Gregory Bird; Yosef Refaeli; Antonio Jimeno
Journal:  Cancer Res       Date:  2016-09-01       Impact factor: 12.701

Review 5.  Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts.

Authors:  Shawna B Matthews; Carol A Sartorius
Journal:  Horm Cancer       Date:  2016-10-28       Impact factor: 3.869

6.  Development of Humanized Mice in the Age of Genome Editing.

Authors:  Vishnu Hosur; Benjamin E Low; Cindy Avery; Leonard D Shultz; Michael V Wiles
Journal:  J Cell Biochem       Date:  2017-05-15       Impact factor: 4.429

7.  Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer.

Authors:  John J Morton; Stephen B Keysar; Loni Perrenoud; Tugs-Saikhan Chimed; Julie Reisinger; Brian Jackson; Phuong N Le; Cera Nieto; Karina Gomez; Bettina Miller; Dexiang Gao; Hilary Somerset; Xiao-Jing Wang; Antonio Jimeno
Journal:  Mol Carcinog       Date:  2018-09-03       Impact factor: 4.784

8.  Transcriptional changes associated with in vivo growth of muscle-invasive bladder cancer cell lines in nude mice.

Authors:  Swathi Ramakrishnan; Wendy Huss; Barbara Foster; Joyce Ohm; Jianmin Wang; Gissou Azabdaftari; Kevin H Eng; Anna Woloszynska-Read
Journal:  Am J Clin Exp Urol       Date:  2018-06-15

9.  Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling.

Authors:  Sushil Kumar; Ratnesh Kumar Srivastava; Snahlata Singh; Ajeya Nandi; Gatha Thacker; Hemma Murali; Sabrina Kim; Mary Baldeon; John Tobias; Mario Andres Blanco; Rizwan Saffie; M Raza Zaidi; Satrajit Sinha; Luca Busino; Serge Y Fuchs; Rumela Chakrabarti
Journal:  Nat Cell Biol       Date:  2020-04-13       Impact factor: 28.824

Review 10.  Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.

Authors:  Yuan Hu; Zhi-Gang Tian; Cai Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-09-07       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.